Showing results (121-130 of 628) with videos related to
Sort By:
Pageof 63
Bulletin Du Cancer|January 15, 2017
Care pathway of patients with metastatic pancreatic cancer in daily practice in France: Results from the REPERE national surveyPascal Hammel, Romain Coriat, Gérard Lledo, et al.Gastroenterologie Clinique Et Biologique|June 2, 2007
[Suspected malignant cancer of the pancreas associated with pseudo-invasive duodenal hamartomas in a patient with Peutz-Jeghers syndrome]Pierre-Emmanuel Rautou, Pascal Hammel, Anne Couvelard, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 10, 2011
Familial intraductal papillary mucinous neoplasms of the pancreasVinciane Rebours, Anne Couvelard, Jean-Luc Peyroux, et al.Pancreas|October 23, 2012
Smoking and the course of recurrent acute and chronic alcoholic pancreatitis: a dose-dependent relationshipVinciane Rebours, Marie-Pierre Vullierme, Olivia Hentic, et al.United European Gastroenterology Journal|August 25, 2021
UEG position paper on pancreatic cancer. Bringing pancreatic cancer to the 21st century: Prevent, detect, and treat the disease earlier and betterPatrick Michl, Matthias Löhr, John P Neoptolemos, et al.Plos One|December 20, 2012
The value of source data verification in a cancer clinical trialCatrin Tudur Smith, Deborah D Stocken, Janet Dunn, et al.Oncotarget|September 24, 2017
Liver cancers with stem/progenitor-cell features - a rare chemotherapy-sensitive malignancyBruno Christian Köhler, Nina Waldburger, Kai Schlamp, et al.Cancers|May 13, 2026
Multiphasic Evidential Decision-Making Matrix (MedMax) for Intrahepatic Cholangiocarcinoma: A Single-Center Validation StudyAli Ramouz, Ali Adeliansedehi, Behboud Moeini Chagervand, et al.Nature Cancer|September 7, 2023
Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDACXu Zhou, Jingyu An, Roma Kurilov, et al.The Journal of Pathology. Clinical Research|November 21, 2018
Novel prognostic markers within the CD44-stromal ligand network in pancreatic cancerOskar Franklin, Ola Billing, Daniel Öhlund, et al.Pageof 63